A
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
Price:
636.45
INR
2.2%
Market Closed
Market Cap:
₹57.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
|
IN |
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
FI |
|
Kunwu Jiuding Investment Holdings Co Ltd
SSE:600053
|
CN |
|
M
|
Mount Logan Capital Inc
NEO:MLC
|
CA |
|
S
|
Shenzhen Worldunion Group Inc
SZSE:002285
|
CN |
|
I
|
Insteel Industries Inc
NYSE:IIIN
|
US |
|
C
|
CNGR Advanced Material Co Ltd
SZSE:300919
|
CN |
Relative Value
The Relative Value of one AARTIPHARM stock under the Base Case scenario is hidden INR. Compared to the current market price of 636.45 INR, Aarti Pharmalabs Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AARTIPHARM Relative Value
HIDDEN
Multiples Across Competitors
AARTIPHARM Competitors Multiples
Aarti Pharmalabs Ltd Competitors
Aarti Pharmalabs Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
A
|
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
|
56.4B INR | 3.2 | 27 | 15.4 | 19.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 41.8 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.1 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
